CytoDyn Inc. (OTCQB:CYDY) continues to be a target for short-sellers who continue to torpedo the bull thesis with weak ammunition and dreadful aim. Despite some critical hits, the bull juggernaut remains afloat and is still on course to commercialization. Captain and CEO Nader Pourhassan continues to rally the bulls with frequent updates and is willing to join the battle to fend-off the shorts. Unfortunately, the seas of the market are getting rough for COVID-19 plays, so CYDY investors should expect the shorts to continue to circle the ticker waiting for an Achilles heel